Patent · US Active

Identifying susceptibility to cardiac hypertrophy

US7572586B2 · kind B2 · utility

0Cited by
2References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 1, 2006
Grant dateAug 11, 2009
Priority date—
Expiry dateMay 15, 2027

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/325
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

This document provides methods and materials related to identifying, assessing, and predicting hypertrophic cardiomyopathy (HCM) in mammals. For example, methods and materials for using mutations (e.g., mutations in ZASP and MYBPC3 nucleic acids) to identify, assess, and predict HCM in mammals (e.g., humans) are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.